🔗 Permalink

Inventor profile of:

Derek O'Hagan

City:

Berkeley, California

Country:

United States

Published Applications:

Last publication date:

2022-10-13

Top Assignees for applications by Derek O'Hagan

The entities that hold a legal rights for patent applications filed by inventor O'Hagan Derek:

Novartis Vaccines and Diagnostics, Inc. 16 Emeryville, CA United States
Chiron Corporation 9 Emeryville, CA United States
Fidia Farmaceutici S.p.A 1 Abano Terme Padua, Italy
Novartis Vaccines and Diagnostics, Inc. 1 Cambridge, MA United States
Novartis Vaccines and Diagnostics SRL 1 Siena, Italy
Novartis Vaccines and Diagonstics, Inc. 1 Cambridge, MA United States
Novarttis Vaccines and Diagnostics, Inc. 1 Emeryville, CA United States
CHIRON SRL 1 Siena, Italy

Recent patent applications by O'Hagan Derek

Derek O'Hagan from Berkeley, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2022-10-13

US20220323577A1

Human necessities

EMULSIONS WITH FREE AQUEOUS-PHASE SURFACTANT FOR ADJUVANTING SPLIT INFLUENZA VACCINES

#2 | 2019-06-06

US20190167786A1

Human necessities

EMULSIONS WITH FREE AQUEOUS-PHASE SURFACTANT FOR ADJUVANTING SPLIT INFLUENZA VACCINES

#3 | 2013-08-01

US20130195923A1

Human necessities

Microemulsions with adsorbed macromolecules and microparticles

#4 | 2012-06-26

US9914279

Microemulsions with adsorbed macromolecules and microparticles

#5 | 2012-05-10

US20120114693A1

Human necessities

NUCLEIC ACID MUCOSAL IMMUNIZATION

#6 | 2011-10-11

US10748117

Immunogenic compositions containing phospholipid

#7 | 2011-06-30

US20110159039A1

Chemistry; metallurgy

ELICITING HCV-SPECIFIC ANTIBODIES

#8 | 2011-06-30

US20110159030A1

Human necessities

MUCOSAL COMBINATION VACCINES FOR BACTERIAL MENINGITIS

#9 | 2010-12-07

US10775964

Microparticle compositions and methods for the manufacture thereof

#10 | 2010-11-23

US10264802

Adjuvanted meningococcus compositions

#11 | 2010-04-01

US20100080823A1

Human necessities

Use of hyaluronic acid polymers for mucosal delivery of vaccine antigens and adjuvants

#12 | 2010-01-07

US20100003280A1

Human necessities

Adjuvant compositions

#13 | 2009-10-20

US10340034

Method of obtaining cellular immune responses from proteins

#14 | 2009-10-15

US20090258033A1

Chemistry; metallurgy

HCV E1E2 vaccine compositions

#15 | 2009-10-06

US10189104

Use of microparticles with adsorbed antigen to stimulate immune responses

#16 | 2009-09-03

US20090220541A1

Human necessities

EMULSIONS WITH FREE AQUEOUS-PHASE SURFACTANT FOR ADJUVANTING SPLIT INFLUENZA VACCINES

#17 | 2009-06-23

US10265083

Adjuvant compositions

#18 | 2009-05-21

US20090130141A1

Human necessities

Compositions and methods for stimulating an immune response against infectious agents

#19 | 2009-04-23

US20090104271A1

Human necessities

Use of microparticles combined with submicron oil-in-water emulsions

#20 | 2009-03-26

US20090081254A1

Chemistry; metallurgy

HIV VACCINE FOR MUCOSAL DELIVERY

#21 | 2008-04-24

US20080095800A1

Chemistry; metallurgy

Eliciting HCV-specific antibodies

#22 | 2008-02-12

US9728423

Eliciting HCV-specific antibodies

#23 | 2008-01-31

US20080026071A1

Chemistry; metallurgy

Microparticles for delivery of heterologous nucleic acids

#24 | 2007-11-15

US20070264285A1

Human necessities

Compositions Comprising Cationic Microparticles And Hcv B1e2 Dna And Methods Of Use Thereof

#25 | 2007-08-23

US20070196391A1

Human necessities

Mucosal boosting following parenteral priming

#26 | 2007-05-24

US20070116709A1

Human necessities

Microemulsions with adsorbed macromolecules and microparticles

#27 | 2006-07-06

US20060147466A1

Human necessities

Mucosal combination vaccines for bacterial meningitis

#28 | 2006-05-25

US20060110736A1

Human necessities

Hiv vaccine formulations

#29 | 2005-12-22

US20050281843A1

Human necessities

Use of bioadhesives and adjuvants for the mucosal delivery of antigens

#30 | 2005-11-17

US20050255124A1

Chemistry; metallurgy

HCV E1E2 vaccine compositions

#31 | 2005-10-13

US20050226937A1

Human necessities

Use of hyaluronic acid polymers for mucosal delivery of vaccine and adjuvants

#32 | 2005-10-06

US20050220883A1

Human necessities

Microparticles with adsorbed polypeptide-containing molecules

#33 | 2005-08-11

US20050175631A1

Chemistry; metallurgy

Hiv vaccine and method of use

#34 | 2005-08-04

US20050169938A1

Human necessities

Plant lectins as mucosal adjuvants

#35 | 2005-06-23

US20050136073A1

Human necessities

Use of microparticles combined with submicron oil-in-water emulsions

#36 | 2005-06-09

US20050123599A1

Human necessities

Immunological adjuvant compositions

#37 | 2005-06-02

US20050118275A1

Human necessities

Immunogenic compositions containing microparticles comprising adsorbed toxoid and polysaccharide-containing antigens

#38 | 2005-05-19

US20050107322A1

Human necessities

Compositions for inducing immune responses

#39 | 2005-05-19

US20050106178A1

Human necessities

Adjuvanted influenza vaccine

#40 | 2005-04-26

US9581772

Microparticles with adsorbent surfaces, methods of making same, and uses thereof

#41 | 2005-03-08

US9696194

Plant lectins as mucosal adjuvants

#42 | 2005-03-01

US10103673

Immunological adjuvant compositions

#43 | 2005-02-15

US10211025

Use of microparticles combined with submicron oil-in-water emulsions

InventorID:

364912 ⎘